Osteoporosis in Rheumatic Diseases

Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Adami, Giovanni, Fassio, Angelo, Rossini, Maurizio, Caimmi, Cristian, Giollo, Alessandro, Orsolini, Giovanni, Viapiana, Ombretta, Gatti, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928928/
https://www.ncbi.nlm.nih.gov/pubmed/31766755
http://dx.doi.org/10.3390/ijms20235867
_version_ 1783482586180354048
author Adami, Giovanni
Fassio, Angelo
Rossini, Maurizio
Caimmi, Cristian
Giollo, Alessandro
Orsolini, Giovanni
Viapiana, Ombretta
Gatti, Davide
author_facet Adami, Giovanni
Fassio, Angelo
Rossini, Maurizio
Caimmi, Cristian
Giollo, Alessandro
Orsolini, Giovanni
Viapiana, Ombretta
Gatti, Davide
author_sort Adami, Giovanni
collection PubMed
description Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patients affected by rheumatic diseases with special focus for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, systemic lupus erythematosus, systemic sclerosis, vasculitides, Sjogren syndrome, and crystal-induced arthritis.
format Online
Article
Text
id pubmed-6928928
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69289282019-12-26 Osteoporosis in Rheumatic Diseases Adami, Giovanni Fassio, Angelo Rossini, Maurizio Caimmi, Cristian Giollo, Alessandro Orsolini, Giovanni Viapiana, Ombretta Gatti, Davide Int J Mol Sci Review Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patients affected by rheumatic diseases with special focus for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, systemic lupus erythematosus, systemic sclerosis, vasculitides, Sjogren syndrome, and crystal-induced arthritis. MDPI 2019-11-22 /pmc/articles/PMC6928928/ /pubmed/31766755 http://dx.doi.org/10.3390/ijms20235867 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Adami, Giovanni
Fassio, Angelo
Rossini, Maurizio
Caimmi, Cristian
Giollo, Alessandro
Orsolini, Giovanni
Viapiana, Ombretta
Gatti, Davide
Osteoporosis in Rheumatic Diseases
title Osteoporosis in Rheumatic Diseases
title_full Osteoporosis in Rheumatic Diseases
title_fullStr Osteoporosis in Rheumatic Diseases
title_full_unstemmed Osteoporosis in Rheumatic Diseases
title_short Osteoporosis in Rheumatic Diseases
title_sort osteoporosis in rheumatic diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928928/
https://www.ncbi.nlm.nih.gov/pubmed/31766755
http://dx.doi.org/10.3390/ijms20235867
work_keys_str_mv AT adamigiovanni osteoporosisinrheumaticdiseases
AT fassioangelo osteoporosisinrheumaticdiseases
AT rossinimaurizio osteoporosisinrheumaticdiseases
AT caimmicristian osteoporosisinrheumaticdiseases
AT giolloalessandro osteoporosisinrheumaticdiseases
AT orsolinigiovanni osteoporosisinrheumaticdiseases
AT viapianaombretta osteoporosisinrheumaticdiseases
AT gattidavide osteoporosisinrheumaticdiseases

Ejemplares similares